Laxative Pills

Product NDC
59779-348
Requested package NDC
59779-348-13
11-digit product format
597790348
Labeler code
59779
Product ID
59779-348_3a2ab1b7-8258-47e7-9458-c82da1549e49
Type
HUMAN OTC DRUG
Nonproprietary name
Sennosides
Dosage form
TABLET
Route
ORAL
Labeler
CVS Pharmacy
Application
part334
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2003-01-02
Marketing end
0000-00-00
Substance
SENNOSIDES
Active strength
25 mg/1
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage59779-34859779-348-13DDiscontinued by firm2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SENNOSIDES A AND BACTIVE INGREDIENT1B5FPI42ENLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
SENNOSIDES A AND BACTIVE MOIETY1B5FPI42ENLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
ACACIAINACTIVE INGREDIENT5C5403N26OLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
CALCIUM CARBONATEINACTIVE INGREDIENTH0G9379FGKLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSINACTIVE INGREDIENTL11K75P92JLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
CARNAUBA WAXINACTIVE INGREDIENTR12CBM0EIZLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61ULAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30LAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
MALTODEXTRININACTIVE INGREDIENT7CVR7L4A2DLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1ALAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
POLYVINYL ALCOHOLINACTIVE INGREDIENT532B59J990LAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3LAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OHLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
SHELLACINACTIVE INGREDIENT46N107B71OLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EULAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
SUCROSEINACTIVE INGREDIENTC151H8M554LAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
TALCINACTIVE INGREDIENT7SEV7J4R1ULAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
59779-348-1359779034813250 TABLET in 1 BOTTLE, PLASTIC (59779-348-13) 250 tablet2003-01-020000-00-00NoNoCurrent